Cytokinetics, Inc. (CYTK)
77.22
+2.41
(+3.22%)
USD |
NASDAQ |
May 13, 16:00
77.22
0.00 (0.00%)
After-Hours: 17:18
Cytokinetics Cash from Investing (Quarterly) : 145.49M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | -131.00M |
| Regeneron Pharmaceuticals, Inc. | -428.90M |
| Sarepta Therapeutics, Inc. | -134.39M |
| Moderna, Inc. | -76.00M |
| Revolution Medicines, Inc. | 172.62M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -145.46M |
| Cash from Financing (Quarterly) | 7.77M |
| Free Cash Flow | -548.92M |
| Free Cash Flow Per Share (Quarterly) | -1.228 |
| Free Cash Flow to Equity (Quarterly) | -155.87M |
| Free Cash Flow to Firm (Quarterly) | -118.05M |
| Free Cash Flow Yield | -5.86% |